An effective COPD case finding strategy in Primary Care

Slides:



Advertisements
Similar presentations
Definition of COPD COPD is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual.
Advertisements

GOLD MANAGEMENT PLAN FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Pulmonary Function Testing
Caring for Patients with COPD: Guidelines for Diagnosis and Management M. Elizabeth Knauft, MD MS September 20, 2007.
BY DR.Khaled Helmy Chest Specialist Al Mahmora Chest Hospital Ministry of Health - Egypt COPD SCOPE ON.
Is it really COPD? Dr Rod Taylor Consultant Respiratory Physician Calderdale Royal Hospital Dr Rod Taylor Consultant Respiratory Physician Calderdale Royal.
Optimizing the Management of Chronic Obstructive Pulmonary Disease (COPD) Note to the Speaker: All bold underlined statements must be read aloud to the.
Academy Board Prep PCCM
Identifying COPD in primary care: targeting patients at the highest risk What is COPD? Chronic obstructive pulmonary disease or COPD is a long-term inflammatory.
8 th ANNUAL CONGRESS OF TURKISH THORACIC SOCIETY April 27 – May 1, 2005 Antalya, TURKEY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN WORKERS OF FERROCHROME.
Applied Epidemiology Epidemiology of Chronic Obstructive Pulmonary Disease (COPD) By Chris Callan 23 April 2008.
Criner et al. NEJM 2014: 370; 23 Simvastatin for the Prevention of Exacerbations in Moderate-to-Severe COPD (STATCOPE) Presented by Ali Naqvi, MD.
COPD (Chronic Obstructive Pulmonary Disease)
COPD MANAGEMENT FALLS SHORT AT RCRMC Jean Solomon, M.D.
Definition of COPD COPD is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual.
COPD Management of Stable COPD Shyam Rao May 2014.
Practice Support Program in COPD: South Okanagan Project COPD CARE Algorithm South Okanagan, Interior Health Patricia Rattee RRT, CRE Shannon Walker MD,
From needs to priorities. Using a Delphi technique to prioritise the IPCRG Research Needs Statement Osman Yusuf Mike Thomas Anders Ostrem Ioanna Tsiligianni.
© 2013 Global Initiative for Chronic Obstructive Lung Disease
Chronic Obstructive Pulmonary Disease
Interpretation Normal Spirometry Obstructive pattern Restrictive pattern Mixed pattern Small airway obstruction Non-specific ventilatory pattern Probably.
Respiratory COPD/Asthma.
يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11 بسم الله الرحمن الرحیم با سلام.
Burden of major Respiratory Diseases WHO Survey Ryazan region of Russia,
Manila, Philippines. BOLD Manila, Philippines  COPD a growing cause of morbidity & mortality worldwide  5 th leading cause of death (2001)  3rd in.
Cary Peterson, DO FP PGYIII Supervising Physician: Keith Felstead, DO June 11, 2009.
GOLD Update 2011 Rabab A. El Wahsh, MD. Lecturer of Chest Diseases and Tuberculosis Minoufiya University REVISED 2011.
Community based integrated intervention for prevention and management of Chronic Obstructive Pulmonary Disease in Guangdong, China: cluster randomised.
Presenting Organization Event Name Event Date Presenter Name, Title COPD Essentials for Physicians
COPD Diagnosis & Management Anil Ramineni Specialist Respiratory Physiotherapist Community Respiratory Team.
Chronic Obstructive Pulmonary Disease Austin Paul K.
COPD ) ) Chronic Obstructive Pulmonary Disease. Introduction n COPD is a preventable and treatable disease with some significant extrapulmonary effects.
Maggie Harris Independent Respiratory Nurse Specialist
CAPSTONE PROJECT. Setting the scene- why smoking cessation is important in the treatment of COPD.
Lancet Respir Med 2013; 1: 199–209 R4.신재령 / Prof. 박명재
LSU Journal Club Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD WISDOM study H. Magnussen MD, et al. Nisha Loganantharaj, PGY1 April 21,
Daniel B. Jamieson, Elizabeth C. Matsui, Andrew Belli1, Meredith C. McCormack, Eric Peng Simon Pierre-Louis, Jean Curtin-Brosnan, Patrick N. Breysse, Gregory.
Pulmonary function test. Evaluation of pulmonary function is important in many clinical situations evaluation of a variety of forms of lung disease assessing.
Analysis of chronic obstructive pulomnary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK):
PREVALANCE OF POST-TUBERCULOSIS AIRFLOW OBSTRUCTION IN PATIENTS WHO HAVE COMPLETED PULMONARY TUBERCULOSIS TREATMENT AT TWO INFECTIOUS DISEASES HOSPITALS.
Definition Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation and a range of pathological changes in the lung.
Management of stable chronic obstructive pulmonary disease (2) Seminar Training Primary Care Asthma + COPD D.Anan Esmail.
CHEST 2014; 145(4): 호흡기내과 R3 박세정. Cigarette smoking ㅡ the most important risk factor for COPD in the US. low value of FEV 1 : an independent predictor.
Spirometry tests were carried out by a Respiratory Clinical Nurse Specialist (Respiratory CNS) Participants were referred to see their General Practitioner.
1 Once-daily indacaterol versus twice-daily salmeterol for COPD ; a placebo-controlled comparison R2 정명화 Eur Respir J 2011; 37: 273–279.
Sarah Wilke, Paul W Jones, H Müllerova, Jørgen Vestbo, Ruth Tal-Singer, Frits ME Franssen, Alvar Agusti, Per Bakke, Peter M Calverley, Harvey O Coxson,
By: James Simpson.  Why  What – now featuring definitions  When  Interpretation  CA$H MONEY.
Chronic Obstructive Pulmonary Disease in the Wessex CLAHRC -Respiratory Theme Dr Lucy Rigge, Clinical Research Fellow Collaboration for Leadership in Applied.
Implementation of a lung health clinic in high-risk individuals in South East London: a prospective feasibility cohort study Background In 2013, lung cancer.
Wales Primary Care COPD Audit
COPD 2003.
External multicentric validation of a COPD detection questionnaire.
Chronic Obstructive Pulmonary Disease(COPD)
“Screening: a wasteful use of resources?”
COPD Report 5 Coles Lane, Oakington, Cambridge, CB24 3BA.
Medicines Management – COPD update for LPC Jyoti Saini Hema Patel
David Culliford, Lynn Josephs, Matthew Johnson, Mike Thomas
Asthma-COPD Overlap Syndrome (ACOS) Challenges Diagnosing ACOS
2nd Eurasian Respiratory & Allergy Summit.
Greater Glasgow Outreach Spirometry Service: A model for closer collaboration between primary and secondary care and its impact on chronic lung disease.
Assessing COPD in Primary Care
Prof Dr Guy JOOS Dept Respiratory Medicine Ghent University Hospital
بیماریهای مزمن انسدادی ریه COPD
1st National Spirometry Day 31st March 2004
Interpretation Normal Spirometry Obstructive pattern
Diagnosi della BPCO 1.
Dr Vincent NINANE – CHU Saint-Pierre
Gestione clinica della BPCO
Identificazione del sottogruppo di pazienti responsivi
Khai Hoan Tram, Jane O’Halloran, Rachel Presti, Jeffrey Atkinson
Presentation transcript:

An effective COPD case finding strategy in Primary Care Fragkoulis Evangelos, Kyriakaki A, Papathanasiou M, Economou N, Maragiannis K, Mariolis A

Clinical COPD is just the tip of the iceberg…

Background COPD remains widely underdiagnosed worldwide Early identification of COPD would be beneficial to reduce costs, loss of quality of life, and premature death the most effective case finding approach is still unknown

Who to target? “A clinical diagnosis of COPD should be considered in any patient who has dyspnea, chronic cough or sputum production, and a history of exposure to risk factors for the disease” GOLD – updated 2016

Methods a pilot study to evaluate the effectiveness of an opportunistic, targeted screening program for COPD in Primary Care. Patients from different types of general practice settings (urban, semi-urban and rural) were included- Athens (centre, suburbs), Mani, Rhodes – 5GPs/ each GP enrolled 50 patients patients were invited opportunistically at routine primary care visits High risk patients for COPD targeted (smokers, having ≥1 respiratory symptom) Smoking status Smokers completed a questionnaire about chronic respiratory symptoms (i.e. cough, sputum production, wheezing and dyspnea) and a short validated COPD screener questionnaire.

The COPD Population Screener™ (COPD-PS™) an easy-to-use, validated tool designed to identify patients at risk for COPD • Score 5-10: High risk of COPD • Score 0-4: Low risk of COPD

eligibility criteria ≥ 40 years smokers or ex-smokers ≥1 respiratory symptom present (dyspnea, cough, wheeze or phlegm) no previous diagnosis of COPD Eligible patients were offered a spirometry

Diagnosis of COPD Spirometry is required to make a clinical diagnosis of COPD post-bronchodilator FEV1/FVC < 0.70 confirms the presence of persistent airflow limitation and thus of COPD • Mild COPD: FEV1 <80% of expected • Moderate COPD: 50%< FEV1 <80% of expected • Severe COPD: 30%< FEV1 <50% of expected GOLD- updated 2016

Results 250 patients were included. 213 had an acceptable spirometry (47 Female, 22%) From them, 82 patients (38.5%) were diagnosed with COPD (FEV1 / FVC <70%) The majority of them had mild (41,4%) or moderate (48,7%) obstruction The number needed-to-screen (NNS) for a new diagnosis of COPD was 2,6

Conclusion Targeting those at higher risk (e.g., smokers) and pre-screening (e.g., using questionnaires) consist a highly effective and feasible strategy to identify undetected patients with COPD in Primary Care.